1. Home
  2. NAGE vs ARRY Comparison

NAGE vs ARRY Comparison

Compare NAGE & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAGE
  • ARRY
  • Stock Information
  • Founded
  • NAGE 1999
  • ARRY 1989
  • Country
  • NAGE United States
  • ARRY United States
  • Employees
  • NAGE N/A
  • ARRY N/A
  • Industry
  • NAGE Medicinal Chemicals and Botanical Products
  • ARRY Semiconductors
  • Sector
  • NAGE Health Care
  • ARRY Technology
  • Exchange
  • NAGE Nasdaq
  • ARRY Nasdaq
  • Market Cap
  • NAGE 861.0M
  • ARRY 785.6M
  • IPO Year
  • NAGE N/A
  • ARRY 2020
  • Fundamental
  • Price
  • NAGE $13.44
  • ARRY $7.40
  • Analyst Decision
  • NAGE Strong Buy
  • ARRY Buy
  • Analyst Count
  • NAGE 3
  • ARRY 20
  • Target Price
  • NAGE $16.67
  • ARRY $9.47
  • AVG Volume (30 Days)
  • NAGE 930.6K
  • ARRY 5.6M
  • Earning Date
  • NAGE 08-06-2025
  • ARRY 08-07-2025
  • Dividend Yield
  • NAGE N/A
  • ARRY N/A
  • EPS Growth
  • NAGE N/A
  • ARRY N/A
  • EPS
  • NAGE 0.18
  • ARRY N/A
  • Revenue
  • NAGE $107,925,000.00
  • ARRY $1,064,767,000.00
  • Revenue This Year
  • NAGE $26.21
  • ARRY $23.50
  • Revenue Next Year
  • NAGE $20.91
  • ARRY $11.23
  • P/E Ratio
  • NAGE $75.10
  • ARRY N/A
  • Revenue Growth
  • NAGE 29.77
  • ARRY N/A
  • 52 Week Low
  • NAGE $2.31
  • ARRY $3.76
  • 52 Week High
  • NAGE $14.49
  • ARRY $12.62
  • Technical
  • Relative Strength Index (RSI)
  • NAGE N/A
  • ARRY 54.53
  • Support Level
  • NAGE N/A
  • ARRY $6.64
  • Resistance Level
  • NAGE N/A
  • ARRY $8.09
  • Average True Range (ATR)
  • NAGE 0.00
  • ARRY 0.59
  • MACD
  • NAGE 0.00
  • ARRY -0.05
  • Stochastic Oscillator
  • NAGE 0.00
  • ARRY 55.87

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: